Skip to main content

Volume 28 - Issue 7 - July 2016

Original Research
07/06/2016
A new surfactant-based biomaterial containing the antimicrobial 1% silver sulfadiazine (SSD) was developed at the University of Virginia (Charlottesville, VA) to improve outcomes for nonhealing wounds. This study’s objective was to clinically...
A new surfactant-based biomaterial containing the antimicrobial 1% silver sulfadiazine (SSD) was developed at the University of Virginia (Charlottesville, VA) to improve outcomes for nonhealing wounds. This study’s objective was to clinically...
A new surfactant-based...
07/06/2016
Wounds